Introduction
Mesenchymal cells require anchorage to extracellular matrix for proliferation (Otsuka and Moskowitz, 1975) . This requirement is a ®rm foundation for proper development and body formation of multicellular organisms. However, once they are malignantly transformed, they can proliferate without anchorage. This ability, which is demonstrable as colony formation in semi-solid medium such as soft agar and methylcellulose, is thought to be one of the fundamental properties of malignant cells because it well correlates with tumorigenicity and metastatic capability (Cifone, 1982; Freedman and Shin, 1974; Stein, 1979) .
In mammals, execution of D cyclin-dependent kinases is essential for onset of S phase (Baldin et al., 1993; Bates et al., 1994; Hengstschlager et al., 1999; Jinno et al., 1999a) . Fibroblasts express D1 and D3 as major D cyclins and Cdk4 and Cdk6 as their kinase partners (Bates et al., 1994; Sherr, 1995) . Interestingly, among the D cyclin-kinase combinations, the Cdk6-D3 complex evades inhibition by CKIs (Lin et al., 2001) . Consequently, this complex has a unique ability to regulate cell's growth potential particularly under growth suppressive conditions where CKIs such as p27 KIP1 and p21 CIP1 are abundantly expressed. A major target for the D-dependent kinases is retinoblastoma protein (Rb) (Matsushime et al., 1992) . These kinases, in cooperation with Cdk2, inactivate Rb by direct phosphorylation, which leads to activating the E2F-DP1 transcriptional factor complex that controls the expression of genes essential for onset of S phase Kato et al., 1993; Weinberg, 1995; Dyson, 1998; Grana et al., 1998; Helin, 1998) . Among those are CDC6, cyclin A, E2F-1, E2F-3 and PCNA. Cdc6 protein plays a critical role in the initiation of S phase by loading the MCM complex onto the replication origins bound to the ORC complex, thereby promoting the initiation of DNA replication (Coleman et al., 1996; Stoeber et al., 1998; Yan et al., 1998; Mendez and Stillman, 2000; Madine et al., 2000) . During cell cycling, Cdc6 protein is additionally regulated by ubiquitin-dependent proteolysis and changes in subcellular localization coupled or uncoupled to phosphorylation by Cdks that occur during G 2 , M phase and quiescence (Petersen et al., 1999 (Petersen et al., , 2000 Coverley et al., 2000) . Independently, Cdk2 is required for the activation of replication origins and subsequent S phase progression (Reed, 1997) .
The rat ®broblast NRK-49F cells can reversibly be transformed by a combination of the two growth factors EGF and TGF-b (Roberts et al., 1981) . In this transformation, TGF-b plays an auxiliary role by enhancing EGF signaling via upregulating the EGFreceptor (Masuda et al., 1992; Kizaka-Kondoh et al., 2000) and it can be substituted by a variety of other stimuli including retinoic acid, prostaglandin F2a and endothelin-1 (Lahaye et al., 1999) . When stimulated with serum, this cell absolutely requires anchorage for entry into S phase, like other ®broblasts, and without anchorage it arrests in G 1 . However, stimulation with the oncogenic growth factors overrides anchorage requirement and enables the cell to enter S phase synchronously in anchorage-free semisolid medium (Kume et al., 1992) .
In ®broblasts, deprivation of anchorage leads to repression of cyclin D1 and induction of p27 KIP1 with concomitant inactivation of Cdk4/6 and Cdk2 (Zhu et al., 1996; Fang et al., 1996; Kawada et al., 1997; Resnitzky, 1997) , which in turn leads to repression of E2F-regulated genes and inability to activate origins of replication, causing G 1 arrest. But when cells are released from hydroxyurea block in early S, anchorage deprivation little in¯uences their progression through the rest of the cell cycle until returning to G 1 (Kume et al., 1992) . Thus, at least these G 1 cyclin-dependent kinases are critical cell cycle targets for the restriction of the G 1 -S transition by anchorage loss. However, we have recently found that activation of both Cdk6/4 and Cdk2 is insucient for inducing anchorage-free S phase entry (Jinno et al., 1999b) , indicating the presence of an additional anchorage-requiring cell cycle factor(s) after the execution of the G 1 cyclin dependent kinases and before the hydroxyurea block point.
Here we report that Cdc6 is a crucial anchoragerequiring cell cycle factor residing between the execution of the G 1 cyclin dependent kinases and the hydroxyurea block point and that the G 1 cyclindependent kinases and Cdc6 constitute major cell cycle targets for the regulation of the G 1 -S transition by anchorage and oncogenic stimulation in NRK cells.
Results

Anchorage loss shuts off expression of Cdc6
To search for the putative anchorage-requiring cell cycle factor(s) functioning after the execution of the G 1 cyclin-dependent kinases and before the hydroxyurea block point, we used one of the NRK-49F cell clones engineered to overexpress both Cdk6 and cyclin D3 (Lin et al., 2001) . In these cells, Cdk6 is highly active even at anchorage loss-imposed G 1 arrest as well as under growth suppressive conditions, such as high cell density and serum depletion, due mainly to the ability of the Cdk6-D3 complex to evade inhibition by p27 KIP1 and p21 CIP1 . Because of at least partial inactivation of retinoblastoma protein (Rb) by active Cdk6 with presumable resulting reciprocal activation of the E2F-DP1 transcriptional complex, these overexpressors phenotypically resemble the cells ablated for the Rb family (Sage et al., 2000; Dannenberg et al., 2000) and highly resist cell/cell contact-and serum depletionimposed G 1 arrest, but they still cannot perform anchorage-independent S phase entry (Lin et al., 2001) .
The clone K6D3 used in this study overexpresses Cdk6 threefold and D3 ®vefold. We ®rst con®rmed that the E2F-DP1 transcriptional complex was at least partially activated in K6D3. Both original NRK and K6D3 were transiently co-transfected with an expression vector containing an E2F enhancer element, together with an expression vector containing the Cytomegalovirus (CMV) promoter as a reference promoter. After 36 h incubation to allow the cells to recover, cells were split into halves. One half was replated and the other half was embedded in methylcellulose semisolid medium followed by incubation for another 36 h. Cells were then harvested from the plates and methylcellulose medium, and the marker luciferase proteins exposed from both experimental and reference vectors were quanti®ed, and the relative activity of the E2F-dependent promoter to the reference CMV promoter was calculated for each cell and for each condition. As shown in Table 1 , the activity of the E2F enhancer-dependent promoter relative to the CMV promoter at anchorage lossimposed G 1 arrest in original NRK cells was very low, but its activity in K6D3 was comparable to those in NRK and K6D3 growing on plates, as expected.
Given this con®rmation, we compared the expression of major factors essential for the activation of replication origins or related in between K6D3 and NRK cells. Both original NRK and K6D3 were arrested in G 1 by incubation in methylcellulose, stimulated to enter S phase in the absence of anchorage by the addition of EGF+TGF-b with cell sampling every 3 h, and examined for their cell cycle progression and the time-dependent expression of major S phase onset factors by Western blot (Figure 1 ). Both cells began entering S phase at 12 h post-stimulation and most of them reached the G 2 /M phase by 21 h. Con®rming the previous result (Lin et al., 2001) , Cdk6 was already active at the arrest point (0 h) in K6D3 cells. By contrast, in both cells, Cdk2 was inactivated at the arrest point and activated with concomitant reduction in p27 KIP1 by subsequent stimulation with EGF+TGF-b. Western blot analysis revealed that all the Mcm subunits, which are essential for the activation of replication origins, were constitutively expressed in both NRK and K6D3 cells at 0 h and thereafter during the oncogenic stimulation though the levels of Mcms 2, 4, 7 were elevated in K6D3. Among other S phase-critical factors examined, at least cyclin A, E2F1, E2F3, PCNA and Cdc6 are reportedly regulated by the E2F-DP1-Rb transcriptional complex (Hateboer et al., 1998; Helin, 1998) , which is at least partially activated by active Cdk6. Consistently, both cyclin A and E2F-1 proteins were already induced at the G 1 arrest in K6D3, but not in parental NRK. Subsequent stimulation with EGF+TGF-b did not in¯uence the levels of these proteins in K6D3, but The relative activities of an E2F-dependent promoter to the CMV promoter are shown with arbitrary ratios. The control vector pTALuc (no E2F site) showed a very low level of relative activity (50.05) that was virtually identical in each cell and each growth condition. The values are averaged from three independent experiments markedly induced those in NRK. PCNA and E2F3 behaved dierently. In NRK cells, PCNA was detectable at 0 h and induced upon oncogenic stimulation whereas in K6D3 cells it was fully induced prior to stimulation. On the other hand, E2F3 was expressed to a full level in pre-stimulated NRK cells and its level was the same as in K6D3 cells, indicating that unlike the cyclin A and E2F1 promoters, these ones are likely to depend not only on E2F-DP1 but also on other transcriptional factors that are perhaps responsive to serum. By contrast, in K6D3 cells, Cdc6, which is required for the activation of replication origins, was not detectable at 0 h and induced by subsequent oncogenic stimulation, indicating that expression of Cdc6 was shut o at the anchorage-free G 1 arrest point despite activation of E2F-DP1 and that this shuto was overridden by oncogenic stimulation. The Cdc6 shuto at anchorage loss-imposed G 1 arrest despite activation of E2F-dependent promoters was not speci®c to NRK cells. The same results were obtained with BALBc3T3 and C3H10T1/2 cells overexpressing both Cdk6 and cyclin D3 (unpublished data).
Cdc6 expression is shut off at transcriptional and post-transcriptional levels
Northern blot analysis was performed for the CDC6, cyclin A and E2F1 transcripts in the same experiment as in Figure 1 . In K6D3 cells, considerable amounts of both cyclin A and E2F-1 transcripts were already induced at 0 h as expected though subsequent stimulation with EGF+TGF-b increased the levels of these transcripts 2 ± 3-fold (Figure 2a) , further con®rming that when excessively produced in an active form, a Ddependent kinase is sucient for partial activation of these E2F-dependent genes though Cdk2 is needed for their full activation. By contrast, the amount of CDC6 transcripts was very low at the arrest and markedly induced by the oncogenic stimulation. Consistent with the absence and subsequent induction of their protein products in original NRK (Figure 1 ), all these genes were inactive at the arrest in this cell and markedly activated by the oncogenic stimulation. These results indicate that anchorage loss led to reduction in the CDC6 transcript despite partial activation of E2F-dependent promoters. The anchorage loss-imposed shuto of Cdc6 expression was executed also at a post-transcriptional level. NRK cell clones constitutively expressing CDC6 transcripts were constructed by stable transfection with a CMV-based vector inserted with the human CDC6 coding region. When two independent NRK cell clones constitutively expressing CDC6 transcripts were embedded in anchorage-free methylcellulose medium to be arrested in G 1 , Cdc6 protein eventually disappeared despite the presence of the transcript (Figure 2b ).
During cell cycling through G 2 and M phase and at quiescence, Cdc6 protein is degraded by ubiquitindependent proteolysis, and the ubiquitin-proteasome is the sole proteolytic system that is known to regulate Cdc6 protein (Petersen et al., 1999; Petersen et al., Figure 1 Cdc6 protein is not expressed at anchorage lossimposed G 1 arrest despite activation of E2F-dependent promoters. NRK and K6D3 cells (Lin et al., 2001) were arrested in G 1 by incubation for 48 h in 1.17% methylcellulose-DMEM supplemented with 5% FCS. The cells were then stimulated to start cell cycling by adding 5 ng/ml each of EGF and TGF-b with sampling cells every 3 h followed by lysis. Cell lysates (20 mg protein per lane) were electrophoresed on SDS-polyacrylamide gels and immunoblotted with the antibodies to the factors shown in the ®gure. In parallel, Cdk6 and Cdk2 were immunoprecipitated and assayed for activities as described (Jinno et al., 1999b) . The asterisk shows Cdk6 activity assayed with 10 times more lysates. In addition, their cell cycle progression was monitored bȳ ow cytometry (Jinno et al., 1999b ) (low ®gures). In this experiment, Orc1 protein was used as a loading control 2000; Coverley et al., 2000) . The disappearance of Cdc6 at anchorage loss-imposed G 1 arrest, however, could not be blocked by the speci®c proteasome inhibitor lactacystin, unlike its degradation at serum depletion-induced quiescence (Petersen et al., 2000) ( Figure 2c ) and during cell cycling. Instead, it was blocked at least partially by the calpain inhibitor ALLN (Inoue et al., 1991) and less eectively by MG-132 the inhibitor of both proteasome and calpain (Petersen et al., 2000) , suggesting that a calpain or related protease is responsible for the Cdc6 protein disappearance at the anchorage loss-imposed G 1 arrest.
Cdc6 is a major downstream target for regulation of G1-S transition by anchorage
There was a notable coincidence between the activation of Cdk2 and the expression of Cdc6 protein during stimulation with EGF+TGF-b (Figure 1 ). This coincidence raises the possibility that the expression of Cdc6 protein might depend not only on E2F-DP1 but also on Cdk2, and that the anchorage loss-imposed shuto of Cdc6 expression might simply be a consequence of anchorage loss-imposed inactivation of Cdk2. This possibility, however, could be excluded. Previously, we showed that mere activation of Cdk6/4 and Cdk2 by providing a brief anchorage during serum stimulation was insucient for inducing S phase entry in the absence of further anchorage (Jinno et al., 1999b) . We performed the same experiment and examined the expression of Cdc6 protein by Western blot. In this experiment, Cdc6 protein failed to be induced despite full activation of both Cdk6/4 and Cdk2 (Figure 3a , V1 lane 4), unlike when NRK cells were stimulated with serum in the presence of anchorage or stimulated with the oncogenic growth factors in the absence of anchorage (Figure 3a, V1  lanes 1 and 3) . This result indicates that the expression of Cdc6 protein and the activity of Cdk2 were regulated independently by loss of anchorage although the possibility of the requirement for Cdk2 activity in Cdc6 expression still remains. This in turn suggests that (Chomczynski and Sacchi, 1987) , and 20 mg aliquots were electrophoresed in a 1.1% agarose gel containing MOPS-buered 2.2 M formaldehyde. Separated RNA was blotted on a ®lter and hybridized with a radio-labeled probe of the 1 kb rat CDC6 cDNA EcoRI-BamHI fragment, the 0.8 Kb rat cyclin A cDNA BamHI-HindIII fragment or the 0.2 Kb rat E2F-1 cDNA EcoRI-BamHI fragment (Hosokawa et al., 1995) . (b) Anchorage loss facilitates disappearance of Cdc6 protein from the cells constitutively expressing human CDC6 cDNA. Two Cdc6-overexpressing NRK cell clones #3 and #17 and one empty vector-transfected control clone V1 were grown in a logarithmic phase and embedded in methylcellulose DMEM supplemented with 5% FCS followed by incubation for 48 h. Cells were collected at the indicated times, lysed and assayed for Cdc6 by Western blot. In parallel, poly A RNA was recovered from each lysate and detected for human CDC6 cDNA transcripts by PCR. (c) A calpain inhibitor, but not a proteasome inhibitor blocks anchorage loss-facilitated disappearance of Cdc6 protein. In the same experiment as in a, at 24 h, MG-132 (inhibitor for both proteasome and calpain), lactacystin (proteasome inhibitor) and ALLN (calpain inhibitor) were added in the medium at concentrations of 100 nM, 10 mM and 10 mM, respectively, and incubated for 24 h. The level of Cdc6 protein was similarly determined by Western blot. In parallel, the same cells were arrested in quiescence by serum starvation for 48 h as described (Jinno et al., 1999a) and incubated in the presence of the same inhibitors for 24 h Requirement for anchorage in Cdc6 expression S Jinno et al Cdc6 nicely ®ts a candidate for an additional putative target(s) for anchorage loss-invoked G 1 arrest that resides before the hydroxyurea block point and after the activation of the G 1 cyclin-dependent kinases. We therefore tested whether or not a combination of a brief anchorage to activate both Cdk6/4 and Cdk2 with enforced expression of Cdc6 could induce S phase entry without further anchorage or oncogenic stimulation at least partially. Several independent NRK cell clones engineered to constitutively express Cdc6 protein, together with empty vector-transfected NRK cell clones as a negative control for no enforced Cdc6 expression, were arrested in G 1 by serum depletion, stimulated with serum for 4 h, detached from the plates, then embedded in methyl cellulose medium and incubated for a total 18 h. As another negative control for this experiment, cells were directly embedded in methylcellulose medium without 4 h stimulation and incubated for a total 18 h whereas as positive controls, cells were stimulated on the plates with serum or in methyl cellulose medium with the oncogenic growth factors for a total 18 h. At the end of incubation, cells were harvested, and the level of Cdc6 protein and the activities of Cdk6/4 (assayed as a combined activity) and Cdk2 were assayed for two representative overexpressor and one control clones (Figure 3a) . Meanwhile, in the same experiment, incubation was continued for a total 21 h and the population of the cells that had entered S phase was determined for independently isolated four overexpressor and three control clones (Figure 3b ). When the control empty vector-transfected NRK cell clones were given anchorage only for 4 h during serum stimulation, virtually no cells entered S phase over the background levels that were likely to be caused by the cells presumably arrested in early S or late G 1 after anchorage-requiring points during serum depletion (Figure 3b ), con®rming the previous result (Jinno et al., 1999b) . However, in the same experiment, a considerable population (50 ± 70% full induction after subtraction of the background) of the NRK cell clones constitutively expressing Cdc6 entered S phase without further anchorage or stimulation with EGF+TGF-b. Under these conditions, both Cdk6/4 and Cdk2 were fully activated and Cdc6 was expressed, but its amount was slightly lower than in those fully stimulated by the oncogenic growth factors or given full time anchorage. When 4 h anchorage was not given, these clones failed to enter S phase despite the expression of a considerable amount of Cdc6 protein (see also Figure  3a , lane 2). This failure was presumably attributable at least partly to the absence of full activation of both Cdk6/4 and Cdk2 without 4 h anchorage during growth stimulation with serum.
Discussion
Mesenchymal cells including the presently used rat ®broblast NRK-49F require anchorage to transit from G 1 to S phase, but not any more after malignant transformation. Previously, it was shown that at least activation of both Cdk6/4 and Cdk2 via induction of cyclin D1 and concomitant repression of p27 KIP1 and p21 CIP1 require anchorage (Fang et al., 1996; Zhu et al., 1996; Kawada et al., 1997; Resnitzky, 1997 ). Our present work shows that Cdc6, which plays an essential role in the activation of replication origins, is an additional factor that is critically regulated by anchorage and oncogenic stimulation. The suciency A brief anchorage to activate Cdk6/4 and Cdk2, combined with enforced Cdc6 expression, promotes S phase entry without further anchorage or oncogenic stimulation. The Cdc6-overexpressing NRK cell clones #3, #14, #17 and #25, and the empty vectortransfected control NRK cell clones V1, V2 and V3 were arrested in G 1 by incubation with DMEM containing 0.05% FCS and stimulated for 4 h with 5% FCS. The cells were then detached from the dishes by trypsinization and incubated for 17 h in semisolid DMEM supplemented with 1.17% methylcellulose, 5% FCS, and 5 mM BrdUrd. The cells that had entered S phase were determined by BrdUrd incorporation followed by immunostaining. The data are averaged from counting ®ve dierent area and the bars are standard deviations. Inset shows Western blot of Cdc6 protein in the control and overexpressors that were arrested in G 1 by serum depletion and then incubated for 24 h with or without 100 nM MG-132 in order to demonstrate the expression of exogenously introduced CDC6 in the overexpressors of a brief anchorage combined with enforced expression of Cdc6 to induce S phase entry without further anchorage or oncogenic stimulation at least partially (Figure 3b) suggests that Cdc6 is the major, if not sole, factor that is regulated by anchorage after the activation of G 1 cyclin-dependent kinases and before the hydroxyurea block point. Interestingly, the Cdc6 protein at anchorage loss-imposed G 1 arrest seems to be degraded by a calpain or a related proteolytic system, which diers from the ubiquitin-dependent proteasome system that degrades Cdc6 in quiescence and M phase (Mendez et al., 2000; Madine et al., 2000; Petersen et al., 1999; Petersen et al., 2000; Coverley et al., 2000) . In this regard, it is noteworthy that nCL4, a member of the calpain family, has been identi®ed as a cancer-related gene. The gene encoding this calpain was isolated as a recessive oncogene by using the antisense RNA strategy with NIH3T3 cells as a search host (Liu et al., 2000) . Furthermore, it was reported that this gene is markedly down-regulated in dierentiated and poorly dierentiated types of gastric cancers (Yoshikawa et al., 2000) .
Given our present ®ndings, one important question emerges: Is there any other critical cell cycle target for anchorage loss-imposed restriction of the G 1 -S transition? This question could be addressed by examining whether activation of both G 1 cyclin-dependent kinases together with enforced expression of Cdc6 is sucient for driving cells to enter S phase without anchorage or not. However, as presented, Cdk2 was still inactive at the anchorage loss-imposed G 1 arrest point even in K6D3 cells. Therefore, until a measure that prevents Cdk2 inactivation at this arrest point is found, this remains unanswered although our ®ndings are coherent with the possibility that the G 1 cyclin-dependent kinases and Cdc6 are sole targets for the restriction.
There are con¯icting reports concerning the relative weight of the role of Cdk4/6 and Cdk2 in Rb inactivation and reciprocal E2F-DP1 activation for S phase onset. Connell-Crowley et al., 1997 concluded that phosphorylation by Cdk4/6 is essential and sucient for Rb inactivation whereas Lundberg and Weinberg (1998) indicated that phosphorylation by both Cdk4/6 and Cdk2 is required for Rb inactivation. Our data indicate that when excessively produced in an active form, Cdk6 is sucient to activate at least partially the E2F-dependent promoters although Cdk2 further enhances the activity of these promoters.
Finally, we would like to discuss about cyclin A proposed as a possible anchorage-regulated cell cycle target by Guadagno et al. (1993) . Since their report, it became known that cyclin A gene is regulated by E2F-DP1, which requires for its activation Cdk4/6 and Cdk2 that are inactivated by anchorage loss as already described. Therefore, repression of cyclin A expression upon anchorage loss is a direct consequence of inactivation of Cdk4/6 and Cdk2, being a simple eector of a known regulation. Moreover, many studies suggest a primary role for cyclin A in cell cycle progression after the G 1 -S transition (Desdouets et al., 1995) . Nevertheless, as a critical experimental basis for the proposal, they showed that NRK cells engineered to constitutively express cyclin A could proliferate in anchorage-free medium. However, as shown here, K6D3 cells were unable to perform anchorageindependent proliferation despite constitutively expressing cyclin A, con¯icting with their ®nding. The reason for this discrepancy seems to reside in the culture medium they used. Throughout their experiment, they used 5% fetal calf serum with the addition of 2 nM EGF as a growth stimulant. This concentration of EGF is comparable to the one used in our studies and is sucient to weakly transform NRK cells without TGF-b (Masuda et al., 1992; Kume et al., 1992) . Moreover, in the presence of EGF, various stimuli including retinoic acid, endothelin-1 and prostaglandin can substitute for TGF-b and induce full transformation of NRK cells (Lahaye et al., 1999) . In light of these ®ndings, constitutive expression of cyclin A seems to simply mimic these stimulants, many of which have been shown to act as enhancers of EGF signaling, like TGF-b (Lahaye et al., 1999; Kizaka-Kondoh et al., 2000) .
Materials and methods
Cells and chemicals
The normal rat kidney ®broblast line NRK-49F was maintained as described (Jinno et al., 1999b) . Human CDC6 cDNA was a gift from M Nakamura (Tokyo Medical and Dental University). The antibodies aCdk4 (C-22), aCdk6 (C-21), aCdk2 (M2), aCyclin E (M-20), aE2F1 (C-20), aE2F3 (C-18), ap21(H-164) and aPCNA (PC10) were purchased from Santa Cruz Biotechnology; aRb(G3-245) from PharMingen; aCyclin A from Upstate Biotechnology (NY); aCdc6(DCS-180), aOrc1(7F6/1) and aCdc47/MCM7 (Clone47DC941) from NeoMaker (CA). aMCM2 and aMCM6 antibodies were gifts from Y Ishimi (Mitsubishi Kasei Institute of Life Science). aMCM3, aMCM4 and aMCM5 antibodies were gifts from H Kimura (University of Oxford).
Cell culture in anchorage-free semisolid medium
Cell cycle arrest and start in the absence of anchorage were performed in DMEM containing 1.17% methylcellulose and 5% FCS with or without 5 ng/ml each of EGF and TGF-b as described (Kume et al., 1992) .
Relative E2F-dependent promoter activities in cells
Rapidly proliferating cells were co-transfected with 10 mg of pRL-CMV (reference vector that expresses renilla luciferase) and 10 mg of pTA-Luc (control vector that expresses ®re¯y luciferase but does not contain an E2F-binding site) or 10 mg of pTA-E2F-Luc (experimental vector that expresses ®re¯y luciferase and contains an E2F binding site (Lam et al., 1995) as described (Jinno et al., 1999b) . After 36 h incubation, cells were harvested and split into halves. One half was replated and the other half was embedded in methylcellulose semisolid medium, and both cells were incubated for 36 h followed by cell lysis and quanti®cation of renilla and ®re¯y luciferases expressed. Quanti®cation of luciferases was performed with Lumat LB9507 (Berthold GmbH, Germany). The arbitrary ratio of ®re¯y luciferase activity to renilla luciferase activity was calculated for each cell and each condition. The relative activities of an E2F-dependent promoter to the CMV promoter were calculated by subtracting the arbitrary ratio of pTA-E2F-Luc-transfected cells with the arbitrary ration of pTA-Luc-transfected cells for each cell and each condition.
Construction of NRK cell clones constitutively expressing Cdc6
The coding sequence of a human CDC6 cDNA was ampli®ed by PCR, inserted into a CMV-based expression vector and stably transfected into NRK-49F cells followed by G418 selection as described (Jinno et al., 1999b) . The cell clones constitutively expressing human Cdc6 were identi®ed by detection of both human CDC6-derived transcripts and Cdc6 protein after arrest in quiescence by serum starvation followed by MG-132 addition.
Immunoblot detection
NRK, K6D3, #3, #17, V1 cells (5610 5 each) were lysed with 0.5 ml of ice-cold RIPA buer and lysates (20 mg protein for each lane) were electrophoresed and immunoblotted as described (Jinno et al., 1999b) .
BrdUrd labeling
Logarithmically proliferating cells at a density of 2610 5 cells per 10 cm dish were arrested in G 1 by incubating in DMEM containing 0.05% FCS for 48 h and then stimulated to resume cell cycling with DMEM containing 5% FCS. 4 h later, cells were detached by trypsinization, embedded in 1.17% methylcellulose DMEM containing 5% FCS and 5 mM bromodeoxyuridine (BrdUrd) and incubated for 17 h.
After incubation, cells were ®xed with 70% ethanol, treated with 4 N HCl for 20 min, neutralized with 1 M sodium tetraborate and rinsed with PBS containing 0.5% Triton X-100 and 5% FCS. The cells were then incubated with the mouse anti-BrdUrd antibody (diluted 1 : 1000) (Sigma) and stained with FITC-conjugated anti-mouse IgG (diluted 1 : 100) (Amersham-Pharmacia).
In vitro kinase assay K6D3 (5610 5 ), NRK, V1, #3 and #17 (5610 6 each) cells were lysed with 0.5 ml (for 5610 5 cells) or 2 ml (for 5610 6 cells) of ice-cold immunoprecipitation buer containing 50 mM HEPES (pH 7.5), 150 mM NaCl, 1 mM EDTA, 2.5 mM EGTA, 1 mM DTT, 0.1% Tween-20, 10% glycerol, 0.1 mM PMSF, 1 mg/ml each of leupeptin and pepstatin, 5 mg/ml of aprotinin, 1 mM NaF, 0.1 mM sodium orthovanadate and 10 mM b-glycerophosphate. Lysates were incubated at 48C for 2 h with 0.3 mg of aCdk2 or aCdk6, or with 0.3 mg each of aCdk6 and aCdk4. Protein G-Sepharose suspension (15 ml) (Amersham-Pharmacia) was then added and incubated at 48C for 1 h. Immune complexes were precipitated by centrifugation and washed with ice-cold glycerol-free immunoprecipitation buer. The kinase activities of immuno-puri®ed Cdk2 and Cdk6/4 were assayed as described (Jinno et al., 1999a) .
